Company Signs Agreement with Altamat to Mass Produce MesoGraf™ 3D Printed Materials

Posted on April 3rd, 2014

OTTAWA – Grafoid Inc. is pleased to announce the signing of an agreement with Altamat Inc. for the construction of an atomization facility to produce MesoGraf™graphene-based powders and filaments for 3D printing.

The agreement was signed by Grafoid Chief Executive Officer Gary Economo and by Dr. Hani Henein for Edmonton, Alberta-based Altamat.

The agreement provides Grafoid with the exclusive global rights to apply technologies invented by Dr. Henein for use in a wide range of functionalized powders for 3D printing applications.

Grafoid Inc., with R&D and production facilities in Singapore, Canada and the United States, is an advanced, complete solutions graphene technologies company.

Grafoid believes MesoGraf™ sets the global standard for high-energy density graphene from a globally patented process. That process uniquely transforms raw, unprocessed graphite ore to affordable and scalable, high-purity, few layer graphene.

Altamat Inc. is an advanced materials manufacturing consultancy founded by Dr. Henein, who has expertise in materials process engineering for metals, metallic alloys and composites.

Dr. Henein is a renowned researcher and inventor, a Professor of Material Engineering at the University of Alberta and the developer of innovative, cost effective, environmentally sustainable manufacturing processes.

The atomization facility will be built at Grafoid’s facility located at the Innovation Park technology center in Kingston, Ontario.

“Success in 3D graphene printed materials markets comes from an ability to create the highest performing products at the lowest possible cost on a safe and environmentally sustainable basis,” Mr. Economo said.

As more and more industries adopt additive manufacturing into their production process, it opens doors to companies like Grafoid that can meet industrial demand for the scalable, mass production of new Mesograf- based 3D printable powders and filaments.

“Our agreement with Altamat and Dr. Henein’s engineering expertise adds yet another element to Grafoid’s expanding portfolio of MesoGraf™ graphene development,” Mr. Economo added.

Mr. Economo said Grafoid aims to supply a wide range of Mesograf™-based powders and filaments that will allow manufacturing companies in every industry to utilize additive manufacturing processes to produce their end products on demand, not solely for prototyping purposes.

About Grafoid Inc.

Grafoid, Inc. is a privately held Canadian corporation investing in MesoGraf™ high energy density graphene applications and economically scalable production processes for pristine bilayer and trilayer graphene and MesoGraf™ derivatives from raw, unprocessed, graphite ore. The company is engaged in the development of graphene patent joint ventures globally, in the areas of renewable energy, advanced polymer materials, bio-medicine, thermal dispersion technologies, coatings and a number of classified material development projects. Focus Graphite, Inc. (TSX Venture: FMS)(OTCQX:FCSMF)(FSE:FKC) holds a significant interest in Grafoid on behalf of its shareholders.

Contact:

Grafoid Inc.
Mr. Gary Economo
Chief Executive Officer
1-613-691-1091 ext. 101
geconomo@grafoid.com

www.grafoid.com